| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152184 Nutritional Composition for Improving Muscle Function and Daily Activity |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110150994 Modified Release Formulation |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336124A1 Stable hydrate of a muscarinic receptor antagonist |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105144A Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| 06/22/2011 | CN102100913A Target spot and medicine for treating cerebral injury |
| 06/22/2011 | CN102100842A Traditional Chinese medicine preparation used for treating diaphragmatic spasm |
| 06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
| 06/21/2011 | US7964199 Therapeutic composition comprising a botulinum neurotoxin |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2470731C Corticotropin releasing factor 2 receptor agonists |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011070541A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2011070539A1 Cysteine protease inhibitors |
| 06/16/2011 | WO2007070483A9 Micrornas that regulate muscle cell proliferation and differentiation |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144053 Process for Obtaining Purified Pterostilbene and Methods of Use Thereof |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144015 Methods for treating muscle diseases and disorders |
| 06/16/2011 | US20110142928 Process for the production of calcium compositions in a continuous fluid bed |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142836 B-cell depleting agents for the treatment of chronic fatigue syndrome |
| 06/16/2011 | US20110142793 Composition for treating articular cartilage defect, and method of manufacture thereof |
| 06/16/2011 | CA2782294A1 Cysteine protease inhibitors |
| 06/16/2011 | CA2782292A1 Cysteine protease inhibitors |
| 06/15/2011 | CN102099050A Orally administrable dosage forms comprising angiogenin and uses thereof |
| 06/15/2011 | CN102091205A Liniment containing fortune's drynaria rhizome, safflower and frankincense and preparation method thereof |
| 06/15/2011 | CN102091166A Compound preparation for promoting neuromuscular regeneration and preparation method thereof |
| 06/15/2011 | CN102090560A Synergism of GOS and polyfructose |
| 06/15/2011 | CN101698063B Plaster for treating facial paralysis and preparation method thereof |
| 06/15/2011 | CN101472574B Agent for increasing testosterone level |
| 06/14/2011 | US7960570 Small molecule inhibitors of rotamase enzyme activity |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960412 Selective estrogen receptor modulator |
| 06/14/2011 | US7959933 Activatable recombinant neurotoxins |
| 06/14/2011 | CA2494241C Botulinum toxin pharmaceutical compositions |
| 06/14/2011 | CA2480987C Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/09/2011 | WO2011068208A1 Therapeutic agent for spinal and bulbar muscular atrophy |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011066656A1 Compositions comprising igf1 agonists and uses thereof |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136816 Compounds that modulate intracellular calcium |
| 06/09/2011 | US20110136776 Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same |
| 06/09/2011 | US20110135638 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2329862A1 Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| 06/08/2011 | EP2329723A1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP2328877A2 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions |
| 06/08/2011 | EP1538927B1 Fruit and/or vegetable derived composition |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102088995A Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102085283A Traditional Chinese medicament for treating myositis ossificans |
| 06/08/2011 | CN101128578B Method of inducing differentiation of skeletal muscle cell |
| 06/07/2011 | US7956091 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/03/2011 | WO2011065791A2 Metabolism accelerating composition comprising astragali radix extract |
| 06/03/2011 | WO2011064552A1 Conjugates for delivery of biologically active compounds |
| 06/02/2011 | US20110130460 Increased creatine retention with soluble fibres |
| 06/02/2011 | US20110130455 Nitrate Esters and Their Use For The Treatment of Muscle and Muscle Related Diseases |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130346 Peptide conjugates for delvery of biologically active compounds |
| 06/02/2011 | US20110130331 Modified growth hormones |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
| 06/01/2011 | CN102083399A Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102078597A Methods for treating muscle injuries |
| 06/01/2011 | CN102078391A Medicine for treating neck, shoulder, waist and leg pain |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2468747C Use of pramipexole to treat amyotrophic lateral sclerosis |
| 05/31/2011 | CA2455635C Use of thiazole derivatives for preparing a medicine for protecting mitochondria |